Medicamen Biotech Stock Performance
as on April 24, 2026 at 9:31 pm IST
Day's Low
Day's High
₹253.63₹262.50
1.56%
Downside
1.88%
Upside

52 Week's Low
52 Week's High
₹216.95₹482.40
15.80%
Downside
87.22%
Upside

Medicamen Biotech share price movements today
- Previous Close
- ₹259.48
- Open
- ₹262.00
- Volume
- 20.49K
- Upper Circuit
- ₹311.37
- Lower Circuit
- ₹207.59
- Day's Low - High
- ₹253.63 - ₹262.50
- 52 Week Low - High
- ₹216.95 - ₹482.40
Medicamen Biotech Historical Returns
- 1 Month Return
- + 7.9 %
- 3 Month Return
- -27.46 %
- 1 Year Return
- -41.72 %
- 3 Year Return
- -63.88 %
- 5 Year Return
- -53.32 %
Medicamen Biotech Fundamentals
as on April 24, 2026 at 4:01 pm IST
Market Cap
₹349.46 Cr
Return on Equity (ROE)
4.43
PE Ratio (TTM)
47.54
Return on capital employed (ROCE)
6.71
Industry PE ratio
42.79
Beta (LTM)
0.96
P/B Ratio
2.81
Dividend Yield
0.21
PEG Ratio
279.64
Quarterly Earnings Growth YOY
-44.18
EPS (TTM)
5.16
Sector
Pharmaceuticals
Book Value
167.57
Technical Analysis
Neutral
Medicamen Biotech Stock Valuation
as on April 24, 2026 at 4:01 pm IST
Medicamen Biotech in the last 5 years
Lowest (41.20x)
March 30, 2026
Industry (42.79x)
April 24, 2026
Today (47.54x)
April 24, 2026
Highest (132.87x)
December 6, 2024
Today’s Price to Earnings Ratio: 47.54x
Medicamen Biotech Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Medicamen Biotech with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 349.46 | -10.66% | 0.57 | 6 | 162 | |
| NA | 1,266.18 | 31.91% | 0.51 | 49 | 465 | |
| NA | 42.34 | 2.86% | 0.98 | 2 | 405 | |
| NA | 2,621.56 | 1.41% | 0.58 | 137 | 2,110 | |
| HOLD | 3,346.87 | -9.75% | 0.66 | 168 | 2,387 |
Medicamen Biotech Stock’s Investor Sentiment and Interest
Search interest for Medicamen Biotech Ltd Stock has increased by 55% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:55% versus previous 30 day period
Medicamen Biotech Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Medicamen Biotech Ltd Annual Profit & Loss
Figures in Rupees Crores
Medicamen Biotech Ltd Cash Flow
Figures in Rupees Crores
Medicamen Biotech Corporate Actions
View detailed summary of the earnings and dividend history of Medicamen Biotech.
Medicamen Biotech Ltd Earnings Results
Medicamen Biotech Ltd’s net profit fell -36.89% since last year same period to ₹2.19Cr in the Q3 2025-2026. On a quarterly growth basis, Medicamen Biotech Ltd has generated -17.98% fall in its net profits since last 3-months.
Read More about Earnings ResultsMedicamen Biotech Ltd Dividends May,2025
In the quarter ending March 2025, Medicamen Biotech Ltd has declared dividend of ₹1.00 per share on 30 May 2025 - translating a dividend yield of 0.39%.
Read More about Dividends
Insights on Medicamen Biotech Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up

Retail Investor have increased holdings from 59.03% to 59.39% in Mar 2026 quarter
POSITIVE IMPACTFII Holding Up

Foreign Institutions have increased holdings from 0.02% to 0.10% in Mar 2026 quarter
NO EFFECTAgainst Peers

In the last 3 years, Lupin Ltd has given 224.5% return, outperforming this stock by 288.3%
NO EFFECTAgainst Peers

In the last 1 year, Torrent Pharmaceuticals Ltd has given 23.5% return, outperforming this stock by 65.2%
NO EFFECTPromoter Holding Unchanged

Promoters holdings remained unchanged at 40.46% of holdings in Mar 2026 quarter
NEGATIVE IMPACTPrice Dip

In the last 3 months, MEDICAMEQ stock has moved down by -27.5%
NEGATIVE IMPACTProfit Down

Netprofit is down for the last 2 quarters, 2.67 Cr → 2.19 Cr (in ₹), with an average decrease of 18.0% per quarter
NEGATIVE IMPACTRevenue Fall

Revenue is down for the last 2 quarters, 47.54 Cr → 47.44 Cr (in ₹), with an average decrease of 0.2% per quarter
About Medicamen Biotech Ltd
Revenue: ₹46.91Cr as on December 2025 (Q3 FY26)
Net Profit: ₹1.63Cr as on December 2025 (Q3 FY26)
Listing date: 27 Oct, 2021
Chairperson Name: Rahul Bishnoi
| Organisation | Medicamen Biotech Ltd |
| Industry | Pharmaceuticals |
| CEO | Rahul Bishnoi |
| E-voting on shares | Click here to vote |
FAQs
What is Medicamen Biotech share price today?
Medicamen Biotech share price today stands at ₹257.66 as on at the close of the market. Medicamen Biotech share today touched a day high of ₹262.5 and a low of ₹253.63.
What is the 52 week high and 52 week low range for Medicamen Biotech share?
Medicamen Biotech touched a 52 week high of ₹482.4 and a 52 week low of ₹216.95. Medicamen Biotech share price today i.e. is closed at ₹257.66, which is -46.59% down from its 52 week high and 18.76% up from its 52 week low.
What is Medicamen Biotech's market capitalisation today?
Medicamen Biotech market capitalisation is ₹349.46 Cr as on .
How to buy Medicamen Biotech shares?
To buy Medicamen Biotech shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for MEDICAMEQ or Medicamen Biotech Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Medicamen Biotech shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Medicamen Biotech trading volume today?
Medicamen Biotech trading volume is 20.49K as on . This means that 20.49K shares of Medicamen Biotech were bought and sold on the stock market during today's trading session.